A case that explores the impact of financial incentives from insurance companies on the patient-physician relationship and whether or not they should be disclosed to a patient.
Genetic information is redefining what society and the medical profession considers to be normal and what departures from the norm are deserving of medical intervention.
An ethical case that was eventually decided in the US Supreme Court involves the right of patients to request an independent third-party review if their HMO refuses to authorize treatments or procedures deemed medically necessary.
When patients and physicians disagree on the use of genetic engineering technology, physicians must act in accordance with professional ethics and society's guidelines.